Hai Wu

Title: Innovations in Cancer Treatment by Inventor Hai Wu

Introduction

Hai Wu is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on enhancing immune responses to combat cancer effectively.

Latest Patents

Hai Wu holds a patent for a "Humanized anti-DKK2 antibody and uses thereof." This invention relates to the discovery that inhibiting Dickkopf2 (DKK2) can increase CD8 cytotoxic T lymphocyte (CTL) activity, which in turn attenuates tumor growth and suppresses tumor formation. The methods described in this patent include treating cancer by administering an effective amount of a humanized anti-DKK2 antibody, providing anti-tumor immunity, and stimulating T cell-mediated immune responses. Additionally, the invention encompasses methods for diagnosing cancer and determining the use of immunotherapy treatments or cancer vaccines. Furthermore, it includes a pharmaceutical composition for treating cancer and a kit for implementing these methods.

Career Highlights

Hai Wu is affiliated with Yale University, where he continues to advance his research in cancer immunotherapy. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Hai Wu has collaborated with notable colleagues, including Dianqing Wu and Bo Chen, to further enhance the impact of his research in the field of cancer treatment.

Conclusion

Hai Wu's innovative work in developing a humanized anti-DKK2 antibody represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in the fight against cancer.